Tag: Medtronic

EHCS is an authorized distributor of Medtronic insulin pumps and other diabetes supplies including CGM, infusion sets, and cartridges.

Upgrade Your MiniMed™ 770G to the 780G Software

Upgrade Your MiniMed™ 770G to the 780G Software

February 19, 2024

If you have a Medtronic MiniMed™ 770G pump, you are eligible for a no-cost software upgrade to the MiniMed™ 780G pump until April 27, 2024. Unlocking this advanced technology from Medtronic can help you have the confidence to navigate your unique diabetes journey.

MiniMed 780G from Medtronic

Real-time insulin adjustments and corrections† all day and night

With this software upgrade, you’ll have access to the new Guardian™ 4 sensor, providing you with:

  • Meal Detection™ technology that detects if you’ve accidentally missed a dose* or undercounted carbs and automatically delivers correction† boluses of insulin, as often as every 5 minutes§
  • The ability to set your Glucose targetΔ as low as 100 mg/dL

Your no-cost software upgrade is available until April 27, 2024, so don’t delay — start your upgrade today!

Please note: If you still have Guardian™ 3 sensors, you can use them with your upgraded pump, but you will have to do fingersticks at least 2 times a day.

https://myehcs.com/wp-content/uploads/MED-770G-780G-Comparison.png

Start Your Software Upgrade Today!

Go to Diabetes.shop

How to Initiate a Software Upgrade from the MiniMed™ 770G pump to the MiniMed™ 780G pump

  1. Place your order on Diabetes.shop for the software upgrade and compatible continuous glucose monitor (CGM) sensor. If you don’t already have an online account, you will need to create one.
  2. Obtain a prescription: Medtronic will obtain a prescription from your healthcare provider for the MiniMed™ 780G pump and compatible CGM sensor.
  3. Review software upgrade kit: Medtronic will ship you software upgrade resources and pump instructions for use.
  4. Complete the required online training: Sign in to Diabetes.shop to watch the required training videos that will take about 40 minutes to complete. Once complete, Medtronic will send you an email within 72 hours to let you know your upgrade is available.
  5. Download the Medtronic Diabetes Updater app: Install the Medtronic Diabetes Updater app on a compatible phone. Available on Apple and Google Play app stores.
  6. Upgrade your pump software to the MiniMed™ 780G pump: Follow the step-by-step instructions on the updater app, including signing into your CareLink™ Personal account. You can wear your pump during most of the two-and-a-half-hour upgrade period. Interaction is required during this time. You are finished when you reach “Software Update Successful” on your phone.

FOOTNOTES
*Taking a bolus 15 – 20 minutes before a meal helps to keep blood sugar levels under control after eating.
†Refers to auto correct, which provides bolus assistance. Can deliver all auto correction doses automatically without user interaction, feature can be turned on and off.
§Refers to SmartGuard™ feature. Individual results may vary.
Δ Glucose targets should be set following a consultation with your healthcare provider.
Ω Fingersticks required in manual mode and to enter SmartGuard™. If symptoms don’t match alerts and readings, use a fingerstick. Refer to user guide. Pivotal trial participants spend avg of > 93% in SmartGuard™.
Φ Smart devices sold separately. For a list of compatible devices, visit http://bit.ly/CheckDevices.

MINIMED™ SYSTEM SOFTWARE UPGRADE PROGRAM
This program allows MiniMed™ 770G system users a software upgrade at no charge until April 27, 2024.
•   Software upgrade process is subject to change. The process may result in a healthcare provider office visit and may result in out-of-pocket expenses such as co-pay, depending on insurance coverage. The process may require the completion of product related training.
•   This program includes the insulin pump software only. CGM products and consumables are not included in this offer.
•   Warranty dates do not reset. The replacement warranty date of an insulin pump upgraded with the software will remain the same as the replacement warranty date of the initial pump purchased. Your warranty date does not impact eligibility for a software update.
•   MiniMed™ pumps and software have certain labeling restrictions that may exclude certain populations, including age and type of diabetes. We recommend you consult your healthcare provider regarding your eligibility to receive the software upgrade based on the labeling of the upgrade, which may differ from the labeling of the MiniMed™ 770G pump.
•   Insurance coverage and plan design varies and may impact the ability to upgrade. Coverage is contingent upon your health insurance medical policy guidelines. Restrictions and medical necessity requirements may apply.
•   A valid prescription will be required for this software upgrade. All participants should consult their healthcare provider for all therapy related decisions.
•   Program terms and conditions are subject to change at any time and without notice. Other restrictions may apply.

IMPORTANT SAFETY INFORMATION

Medtronic MiniMed™ 780G System With SmartGuard™ Technology with Guardian™ 4 Sensor

The MiniMed™ 780G system is intended for continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons seven years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 780G system includes SmartGuard™ technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed™ 780G system consists of the following devices: MiniMed™ 780G insulin pump, the Guardian™ 4 transmitter, the Guardian™ 4 sensor, One press serter, the Accu-Chek™ Guide Link blood glucose meter, and the Accu-Chek™ Guide test strips. The system requires a prescription from a healthcare professional.

The Guardian™ 4 sensor is intended for use with the MiniMed™ 780G system and the Guardian 4 transmitter to monitor glucose levels for the management of diabetes. The sensor is intended for single use and requires a p rescrip tion . The Guardian™ 4 sensor is indicated for up to seven days of continuous use.

The Guardian™ 4 sensor is not intended to be used directly to make therapy adjustments while the MiniMed™ 780G is operating in manual mode. All therapy adjustments in manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ 4 sensor. The Guardian™ 4 sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Do not use the Guardian™ 4 sensor in the abdomen or other body sites including the buttocks, due to unknown or different performance that could result in hypoglycemia or hyperglycemia.

WARNING: Do not use the SmartGuard™ feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard™ feature.

WARNING: Do not use the MiniMed™ 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 780G system.

WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard™ feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a BG meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.

Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women, persons with type 2 diabetes, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-780g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library

Tags: , , , , ,

Related Articles

MiniMed 780G from Medtronic

MiniMed 780G from Medtronic

December 12, 2023

The MiniMed™ 780G Insulin Pump system is designed for real life. Ever miss a meal dose sometimes or underestimate a carb count? Life with diabetes can be unpredictable. Now there’s an insulin pump system designed with Meal Detection™ technology* that automatically adjusts and corrects† sugar levels every 5 minutes§.

MiniMed 780G from Medtronic

Helping you Manage Sugar Levels with Real-Time Insights!

The MiniMed™ 780G system gives you greater freedom and peace of mind with real-time adjustments and corrections† every five minutes all day and night§. Powered by advanced SmartGuard™ technology, this system:

  • Anticipates insulin needs based on real-time sugar trends
  • Adjusts insulin delivery to help smooth out highs and lows
  • Corrects† highs automatically§ to help cover underestimated carb counts and an occasionally missed meal dose3


What is meal detection* and how does it work?

The system uses current and past sugar trends to detect a missed meal dose.* If the system detects sugar levels rising it can automatically deliver a stronger correction dose for undercounted carbs every five minutes to help prevent highs.§

.

Ready to get started?

Apply Today

References
*Taking a bolus 15 – 20 minutes before a meal helps to keep blood sugar levels under control after eating.
§ Refers to SmartGuard™ feature. Individual results may vary.
† Refers to auto correct, which provides bolus assistance. Can deliver all auto correction doses automatically without user interaction, feature can be turned on and off.
3. Matejko B. et al, Diabetes Care. 2022;https://doi.org/10.2337/dc220470.

Important safety information: MiniMed™ 780G system with SmartGuard™ technology with Guardian™ 4 sensor

The MiniMed™ 780G system is intended for continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons seven years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 780G system includes SmartGuard™ technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed™ 780G system consists of the following devices: MiniMed™ 780G insulin pump, the Guardian™ 4 transmitter, the Guardian™ 4 sensor, One-press serter, the Accu-Chek™ Guide Link blood glucose meter, and the Accu-Chek™ Guide test strips. The system requires a prescription from a healthcare professional.

The Guardian™ 4 sensor is intended for use with the MiniMed™ 780G system and the Guardian 4 transmitter to monitor glucose levels for the management of diabetes. The sensor is intended for single use and requires a prescription. The Guardian™ 4 sensor is indicated for up to seven days of continuous use.

The Guardian™ 4 sensor is not intended to be used directly to make therapy adjustments while the MiniMed™ 780G is operating in manual mode. All therapy adjustments in manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ 4 sensor. The Guardian™ 4 sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Do not use the Guardian™ 4 sensor in the abdomen or other body sites including the buttocks, due to unknown or different performance that could result in hypoglycemia or hyperglycemia.

WARNING: Do not use the SmartGuard™ feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard™ feature.

WARNING: Do not use the MiniMed™ 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 780G system.

WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard™ feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a BG meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.

Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women, persons with type 2 diabetes, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-780g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library

Tags: , , , , ,

Related Articles

Upgrade Your Medtronic Pump Before Your Benefits Reset!

Contact Us: 1.888.344.3434

Home          Shop Breast Pumps          Support for Moms          FAQs          Why Choose EHCS          Store         

Upgrade Your Medtronic Pump Before Your Benefits Reset!

August 18, 2022

The MiniMed™ 770G insulin pump system automatically adjusts background insulin every 5 minutes.** Using real-time glucose readings, the system is able to calculate a personalized amount of insulin to deliver based on CGM.

upgrade your medtronic pump

This post refers to an older Medtronic insulin pump. Click here to learn about the latest technology in Medtronic insulin delivery with the MiniMed 780G. 

Medtronic MiniMed™ 770G™ Insulin Pump System

The Medtronic MiniMed™ 770G™ insulin pump system is the technology that adapts to you! Approved for ages 2 and up, this new, FDA-approved system connects directly with a compatible smartphone, allowing you to view sugar trends and insulin delivery on the go.

Are you Eligible to Upgrade your Insulin Pump?

UPGRADE TODAY!

Ready to upgrade your Medtronic pump?

The MiniMed™ 770G™ system gives you the flexibility to continue living your life while managing your diabetes! Sometimes referred to as a hybrid closed loop system, it automatically adjusts delivery of basal (background) insulin based on CGM sensor glucose values. This means that the pump gets glucose readings from the CGM automatically, and then delivers a variable rate of insulin 24 hours a day based on your personal needs.** This integrated system – meaning having a pump and a CGM that speak to one another – may help reduce both high and low glucose levels.**

You can even stay up-to-date on your glucose trends and insulin delivery 24/7 using the MiniMed™ Mobile app for iOS and Android. This system adapts to your unique needs, so you can focus on living your life and worrying less about managing your diabetes!

Multiple Features Make Managing Your Diabetes Easier:

  • Data-sharing capability makes virtual and in-person doctor’s appointments easier

  • Smartguard™ Auto Mode helps prevent glucose highs and lows

  • MiniMed™ Mobile App allows you to discreetly check your numbers

  • Carelink™ Connect App brings more peace of mind for care partners

  • Exercise setting may reduce lows during activities

Now may be the best time to upgrade to the 770G system, and get access to Medtronic’s MiniMed™ 780G* software upgrade at no cost, when available. Software upgrades provide the latest pump features without having to switch your physical pump!

*Investigational. Not approved by the FDA for any use and not commercially available in the US. We will let you know as soon as the software upgrade is available with the option to add our future CGM!

**Refers to SmartGuard™ Auto Mode. Some user interaction required. Individual results may vary.

IMPORTANT SAFETY INFORMATION: MINIMED™ 770G SYSTEM WITH SMARTGUARD™ TECHNOLOGY

The MiniMed™ 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 770G System includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose values (SG) and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed™ 770G System consists of the following devices: MiniMed™ 770G Insulin Pump, the Guardian™ Link (3) Transmitter, the Guardian™ Sensor (3), one-press serter, the Accu-Chek® Guide Link blood glucose meter, and the Accu- Chek®Guide Test Strips. The system requires a prescription.

The Guardian™ Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ Sensor (3).

All therapy adjustments should be based on measurements obtained using the Accu-Chek® Guide Link blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.

WARNING: Do not use the MiniMed™ 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 770G system.

Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult http://www.medtronicdiabetes.com/important-safety- information#minimed-770g and the appropriate user guide at http://www.medtronicdiabetes.com/download-library. 

Tags: , , , , , , ,

Related Articles

Insulin Pump Therapy: MiniMed™ 770G Pump from Medtronic

Insulin Pump Therapy: MiniMed™ 770G Pump from Medtronic

April 04, 2022

The Medtronic MiniMed™ 770G insulin pump system is the technology that adapts to you! Approved for ages 2 and up, this new, FDA-approved system automatically adjusts background insulin every 5 minutes.** By using real-time glucose readings from the integrated Guardian Connect continuous monitoring system, the system determines the amount of insulin needed based on your body’s needs.

770g pump from medtronic, medtronic 770g

See Your Sugar Levels And Insulin Delivery Right On Your Smartphone!

The MiniMed™ 770G system, sometimes referred to as a hybrid closed loop system, automatically adjusts delivery of basal (background) insulin based on CGM sensor glucose values. This means that the pump gets glucose readings from the CGM automatically, and then delivers a variable rate of insulin 24 hours a day based on your personal needs.** This integrated system – meaning having a pump and a CGM that speak to one another – may help reduce both high and low glucose levels.**

You can even stay up-to-date on your glucose trends and insulin delivery 24/7 using the MiniMed™ Mobile app for iOs and Android. This system adapts to your unique needs, so you can focus on living your life and worrying less about managing your diabetes!

Multiple Features Make Managing Your Diabetes Easier:

  • Data-sharing capability makes virtual and in-person doctor’s appointments easier

  • Smartguard™ Auto Mode helps prevent glucose highs and lows

  • MiniMed™ Mobile App allows you to discreetly check your numbers

  • Carelink™ Connect App brings more peace of mind for care partners

  • Exercise setting may reduce lows during activities

 

Learn How The MiniMed™ 770G Pump from Medtronic Can Help You Prevent Glucose Highs And Lows!

Ready to get started?

Apply Today

** Refers to SmartGuard™ Auto Mode. Some user interaction required. Individual results may vary.

IMPORTANT SAFETY INFORMATION: MINIMED™ 770G SYSTEM WITH SMARTGUARD™ TECHNOLOGY

 The MiniMed™ 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 770G System includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose values (SG) and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed™ 770G System consists of the following devices: MiniMed™ 770G Insulin Pump, the Guardian™ Link (3) Transmitter, the Guardian™ Sensor (3), one-press serter, the Accu-Chek® Guide Link blood glucose meter, and the Accu- Chek®Guide Test Strips. The system requires a prescription.

The Guardian™ Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ Sensor (3).

All therapy adjustments should be based on measurements obtained using the Accu-Chek® Guide Link blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.

WARNING: Do not use the MiniMed™ 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 770G system.

 Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult http://www.medtronicdiabetes.com/important-safety- information#minimed-770g and the appropriate user guide at http://www.medtronicdiabetes.com/download-library. 

Tags: , , , , ,

Related Articles

Benefits of a MiniMed Insulin Pump

Benefits of a MiniMed Insulin Pump

April 04, 2022

An insulin pump is a small device that mimics the function of your pancreas by providing continuous, customized doses of insulin based on your body’s needs.

Medtronic’s selection of insulin pumps gives you the flexibility to continue living your life while managing your diabetes!

Benefits of a MiniMed Insulin Pump, why use a Medtronic insulin pump

What is Insulin Pump Therapy?

An insulin pump is a small device that mimics the function of your pancreas by providing continuous, customized doses of insulin based on your body’s needs. Insulin pump therapy not only means 90% fewer injections*, but allows for mealtime dosing, more stable blood sugar levels, and accurate insulin delivery!

Not sure how an insulin pump works? Watch the video below!

 

Why Choose a Medtronic Insulin Pump?
Medtronic has more than 35 years of experience, over 1.2 million people living with diabetes served, and offers service and support to help you succeed with your new insulin pump therapy! Medtronic’s systems include intuitive features that help you manage your diabetes better.

SmartGuard™ Auto Mode
The MiniMed™ 670G system is the only system that automatically adjusts background insulin every five minutes based on your sugar levels.†

Benefits of the SmartGuard™ Auto Mode include:

  • Fewer highs and lows 3

  • Personalized diabetes management 3

  • More freedom to focus on your day 3, 9

  • Less effort to manage diabetes 9

Benefits of a MiniMed Insulin Pump, why use a Medtronic insulin pump

Service and Support

  • 24-Hour Technical Support to answer your questions

  • Largest support team consisting of over 2,000 field, clinical and customer care representatives

  • Personalized education and training programs

  • Dedicated insurance service teams to support your insurance needs

Exclusive CareLink™ Software

  • A web-based program that collects information directly from your Medtronic diabetes management system. It allows you to generate reports that can be used during your doctor’s visits and to monitor your own progress.

Learn More About Metronic Insulin Pumps

Learn More

WARNING: Do not use the Suspend on low feature to prevent or treat low glucose. Always confirm your sensor glucose reading using your BG meter, and follow the instructions of your healthcare professional to treat low glucose. Using Suspend on low alone to prevent or treat low glucose may result in prolonged hypoglycemia.
‡ Coverage guidelines for insulin pumps vary and are subject to the insurance companies published medical policies in effect at the time services are requested.
*Assumes four injections per day for 30 days and one infusion set change every two to three days.
† Refers to Auto Mode. Some interaction required. Individual results may vary.
3. Pivotal Trial: Bergenstal R, Garg S, Weinzimer S, et al. Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. JAMA. 2016;316(13):1407–1408.
9. Data on file. Survey of Priority Access patients (n>13,000).
This post is sponsored by Medtronic.

Tags: , , , , ,

Related Articles

Insulin Pump & CGM Therapy for Children: The MiniMed™ 770G System

Insulin Pump & CGM Therapy for Children: The MiniMed™ 770G System

July 29, 2021

The Medtronic MiniMed™ 770G insulin pump system is the technology that adapts to you! Approved for ages 2 and up, this new, FDA-approved system automatically adjusts background insulin every 5 minutes.** By using real-time glucose readings from the integrated Guardian Connect continuous monitoring system, the system determines the amount of insulin needed based on your body’s needs.

770g pump from medtronic, medtronic 770g

 

The Medtronic MiniMed™ 770G system combines insulin pump therapy and continuous glucose monitoring (CGM). The system is able to make adjustments to the amount of background insulin delivered based on your child’s needs, helping reduce highs and lows.*

This system also makes dinner time for your child incredibly easy! Enter the number of carbs that he/she will be eating, and the system will automatically calculate a mealtime insulin dose.

Multiple Features That Make Managing Your Child’s Diabetes Easier:

  • Smartguard™ Auto Mode helps prevent glucose highs and lows
  • MiniMed™ Mobile App allows your child to view his/her pump and CGM info on a smartphone
  • Carelink™ Connect App brings more peace of mind for parents

Learn How The MiniMed™ 770G Insulin Pump System Can Help Your Child Prevent Glucose Highs And Lows!

Learn More About Metronic Insulin Pumps

Learn More

WARNING: Do not use the Suspend on low feature to prevent or treat low glucose. Always confirm your sensor glucose reading using your BG meter, and follow the instructions of your healthcare professional to treat low glucose. Using Suspend on low alone to prevent or treat low glucose may result in prolonged hypoglycemia.
‡ Coverage guidelines for insulin pumps vary and are subject to the insurance companies published medical policies in effect at the time services are requested.
*Assumes four injections per day for 30 days and one infusion set change every two to three days.
† Refers to Auto Mode. Some interaction required. Individual results may vary.
3. Pivotal Trial: Bergenstal R, Garg S, Weinzimer S, et al. Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. JAMA. 2016;316(13):1407–1408.
9. Data on file. Survey of Priority Access patients (n>13,000).
This post is sponsored by Medtronic.

Tags: , , , , ,

Related Articles

Introducing the InPen Smart Insulin Pen

Introducing the InPen Smart Insulin Pen

May 04, 2021

If you like the simplicity of multiple daily injection (MDI) therapy, but want the intelligence of an insulin pump, look no further than the InPen smart insulin pen system.

Finally, you can have sophisticated diabetes technology that’s easy to use – and affordable!

inpen smart insulin pen, inpen from medtronic

The InPen from Medtronic is the first and only FDA-cleared smart insulin pen system that helps you take the right dose, at the right time. By tracking your diabetes data to a smart app via Bluetooth, the InPen system provides personalized recommendations that fundamentally change how you manage MDI. You can dose with the InPen and let the InPen app do the tracking and monitor your active insulin throughout the day.

As InPen user Allison said, “InPen is a game-changer for anyone on multiple daily injections. With help from InPen, I feel more in control of my diabetes because I am confident that I am administering the right doses. I can’t imagine MDI without InPen in my toolbox and highly recommend this to anyone.”

Approved for ages 7 and up, the InPen is compatible with the following short-acting insulins: Fiasp, Humalog, and Novolog cartridges (separate prescription required). You can also log your long-acting insulin doses in the InPen app and set up dose reminders to take your long-acting insulin.

How to get the InPen smart insulin pen

Available through GEM Edwards Pharmacy, most commercial insurance plans cover the InPen, and you may also qualify for other assistance, bringing the cost down to as little as $35 per prescribed pen. After we receive your application, our Diabetes Care team will review your coverage, determine the best way for you to receive InPen, and work with your doctor to get the prescription so we can ship InPen directly to your home!

 

Is InPen from Medtronic right for you?

Learn More

Click to view full InPen safety information

Indications for Use
InPen requires a prescription. It is a home-use reusable pen injector for single-patient use by people with diabetes under the supervision of an adult caregiver or by a patient age 7 and older for the self-injection of a desired dose of insulin. The pen injector is compatible with Lilly Humalog® U-100 3.0 mL cartridges, Novo Nordisk Novolog® U-100 3.0 mL cartridges, and Novo Nordisk Fiasp® U-100 3.0 mL cartridges and single-use detachable and disposable pen needles (not included). The pen injector allows the user to dial the desired dose from 0.5 to 30 units in one-half (1/2) unit increments.
The InPen dose calculator, a component of the InPen app, is indicated for the management of diabetes by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for calculating an insulin dose or carbohydrate intake based on user-entered data.
For an insulin dose based on the amount of carbohydrates, a healthcare professional must provide patient-specific target blood glucose, insulin-to-carbohydrate ratio, and insulin sensitivity parameters to be programmed into the software prior to use.
For an insulin dose based on fixed/variable meal sizes, a healthcare professional must provide patient-specific fixed doses/meal sizes to be programmed into the software prior to use.

Contraindications
The InPen system is not intended for anyone unable or unwilling to:
• Test blood glucose (BG) levels as recommended by a healthcare provider
• Maintain sufficient diabetes self-care skills
• Visit a healthcare provider regularly

InPen is not recommended for the blind or visually impaired without the assistance of a sighted individual trained to use it. Always carry a spare insulin delivery device in case your InPen is lost or damaged.

Tags: , , , ,

Related Articles

Your Cart